China NT Pharma Group Company Limited (1011.HK) HKSE
0.55
+0(+0.00%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.55
+0(+0.00%)
Currency In HKD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
22
First IPO Date
April 20, 2011
| Name | Title | Pay | Year Born |
| Bozhi Zhang | Chief Executive Officer | 0 | 1981 |
| Ching Mei Ng | Executive Director | 846,821 | 1999 |
| Tit Ng | Co-Founder & Executive Chairman | 846,821 | 1964 |
| Jing Fang | Chief Financial Officer | 0 | 1970 |
| Yifang Li | Company Secretary | 0 | 1991 |
China NT Pharma Group Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China and internationally. It manufactures, sells, and trades in prescription medicines for the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products and generic drugs. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Suzhou, the People's Republic of China.